Health News (Reuters)

GSK sees breakthrough in shingles vaccine output in 2024

GlaxoSmithKline said further growth from its shingles vaccine, which has boosted earnings, would be reined in by limited capacity until 2024, but a new bioreactor facility would then be ready to bring a step change in production.

Pakistan deploys new vaccine against 'superbug' typhoid outbreak

Pakistan began vaccinating millions of children against typhoid on Friday to try to control a drug-resistant superbug outbreak of the fever that has already infected some 11,000 people since 2016 and risks spreading internationally.

Diabetes tied to increased risk of hidden spinal fractures

(Reuters Health) - People with type 2 diabetes are more likely than others to develop spinal fractures that sometimes have no obvious symptoms but are tied to increased risk of future broken bones, a research review suggests.

Best surgery for long-term weight loss not yet clear

(Reuters Health) - People with obesity may initially shed more excess pounds with an older operation known as Roux-en-Y gastric bypass than with a newer sleeve gastrectomy procedure, but a research review suggests that longer-term, which one is better for weight loss remains unknown.

Rollout of Johnson & Johnson Ebola vaccine begins in Congo

Health authorities in eastern Congo have introduced a new Ebola vaccine produced by Johnson & Johnson, aid group MSF said on Thursday, to help combat the world's second-worst outbreak of the virus on record.

Pages